Miragen Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $894k | 41k | 21.78 |
| 2023-09-30 | $613k | 40k | 15.34 |
| 2023-06-30 | $1.2M | 49k | 23.79 |
| 2023-03-31 | $657k | 26k | 25.44 |
| 2022-12-31 | $702k | 24k | 29.21 |
| 2022-09-30 | $510k | 25k | 20.41 |
| 2022-06-30 | $211k | 18k | 11.85 |